5′-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5′-Functionalized Nucleosides with Biological Potential
<b>Background/Objectives:</b> While various nucleoside and nucleotide analogs have been approved as anticancer and antiviral drugs, their limitations, including low bioavailability and chemotherapeutic resistance, encourage the development of novel structures. In this context, and motiva...
Saved in:
| Main Authors: | Jennifer Szilagyi, Tânia Moreira, Rafael Santana Nunes, Joana Silva, Celso Alves, Alice Martins, Rebeca Alvariño, Niels V. Heise, René Csuk, Nuno M. Xavier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Jian Wang, et al.
Published: (2025-04-01) -
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss
by: Na Gao, et al.
Published: (2025-03-01) -
Prevention of Hepatitis B Vertical Transmission: Focus on Antenatal Antiviral Administration
by: Anandhara Indriani Khumaedi, et al.
Published: (2016-12-01) -
Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
by: Jihye Lim, et al.
Published: (2025-04-01) -
Chronic Hepatitis B In Elite Athletes
by: T. H. Nguyen, et al.
Published: (2025-03-01)